Bryan Johnson Reveals Autoimmune Gastritis Diagnosis
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Bryan Johnson announced on X he has autoimmune gastritis, a chronic condition in which antibodies destroy acid-producing stomach cells and block iron absorption.
- Autoimmune gastritis affects an estimated 4% of people globally, and gastrointestinal pathologist Toby Cornish said gastroenterologists often fail to recognize it in patients.
- Johnson's earliest clue was consistently low ferritin despite normal hemoglobin and hematocrit readings; a definitive diagnosis required an upper endoscopy with biopsies.
- The U.S. Preventive Services Task Force lowered the recommended colonoscopy screening age from 50 to 45 in 2021, potentially explaining why Johnson — 48 at the time — said he was overdue for the procedure.
- Autoimmune gastritis patients are 13 times more likely to develop neuroendocrine tumors due to a feedback loop in which low stomach acid drives chronic overproduction of gastrin.
- Johnson is exploring CAR-T therapy, an experimental gene therapy approach; Cornish called it "the best line of investigation for finding a cure," though it has not been studied for this specific condition.
Why it matters: Johnson spent $2 million on medical treatments in 2023 alone, yet a disease quietly destroyed his stomach for years — proof that even obsessive self-measurement can't outpace a condition experts routinely miss. With autoimmune gastritis affecting roughly 4% of people worldwide and standard care offering little beyond monitoring, Johnson's CAR-T exploration becomes a high-profile test case for a chronically underserved patient population.
